Nuvation Bio Inc. Cash Equivalents, at Carrying Value
Nuvation Bio Inc. (NUVB) had Cash Equivalents, at Carrying Value of $20.35 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $20.35M.
- 2026-03-31: Cash Equivalents, at Carrying Value $87.63M.
- 2025-12-31: Cash Equivalents, at Carrying Value $96.33M.
- 2025-09-30: Cash Equivalents, at Carrying Value $79.12M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $20.35M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $87.63M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $96.33M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $79.12M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $198.99M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $15.90M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $11.55M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $9.14M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $19.56M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $22.77M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $26.51M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $19.90M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $24.75M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $27.67M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $26.51M 10-Q · filed 2024-05-14 | $68.31M 10-K · filed 2023-03-15 |
| 2022-09-30 | $119.86M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $69.68M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $51.18M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $84.71M 10-K · filed 2023-03-15 | |
| 2020-12-31 | $10.40M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |